DOBUTAMINE-ATROPINE STRESS ECHOCARDIOGRAPHY FOR REVERSIBLE DYSFUNCTION DURING THE FIRST WEEK AFTER ACUTE MYOCARDIAL-INFARCTION - LIMITATIONS AND DETERMINANTS OF ACCURACY
S. Smart et al., DOBUTAMINE-ATROPINE STRESS ECHOCARDIOGRAPHY FOR REVERSIBLE DYSFUNCTION DURING THE FIRST WEEK AFTER ACUTE MYOCARDIAL-INFARCTION - LIMITATIONS AND DETERMINANTS OF ACCURACY, Journal of the American College of Cardiology, 30(7), 1997, pp. 1669-1678
Objectives. We sought to compare the accuracy of biphasic and ischemic
responses and sustained improvement for reversible dysfunction and to
identify causes of false negative and false positive findings. Backgr
ound. Previous studies have shown that low dose dobutamine echocardiog
raphy was accurate for detecting reversible dysfunction after acute my
ocardial infarction (MI) but did not determine whether accuracy was im
proved by peak dose findings or influenced by the test interval or cli
nical or angiographic factors. Methods. Dobutamine-atropine stress ech
ocardiography (DASE) (baseline, low dose [5 and 10 pg/kg body weight p
er min] and peak dose) and coronary angiography were performed in 115
patients 2 to 7 days after MI (test interval). Segmental wall thickeni
ng was analyzed according to the 16-segment model. Sustained improveme
nt and biphasic and ischemic responses included improved wall thickeni
ng at low and peak doses, improved wall thickening at the low dose wit
h worsening at peak dose and no change in wall thickening at the low d
ose with worsening at peak dose, respectively. Follow-up echocardiogra
phy was performed at 4 to 8 weeks, and reversible dysfunction was defi
ned as improved wall thickening. Results. Wall thickening improved at
follow-up in 305 (44%) of 688 dysfunctional segments. The test interva
l was 2 days in 16 patients, 3 days in 24, 4 days in 24, 5 days in 12,
6 days in 16 and 7 days in 23. No change at low and peak doses accura
tely predicted fixed dysfunction (318 [88%] of 360 segments), especial
ly in akinetic and dyskinetic segments (276 [91%] of 303), irrespectiv
e of the test interval or clinical and angiographic factors. Ischemic
segmental responses also predicted fixed dysfunction (63% [12 of 19 pa
tients]), especially in medically treated compared with revascularized
patients (100% [8 of 8] vs. 36% [4 of 11], p = 0.013), Both biphasic
responses and sustained improvement (77% [179 of 231 segments] vs. 87%
[84 of 97], p = 0.082) were highly predictive of reversible dysfuncti
on, especially in akinetic segments, irrespective of the test interval
or clinical and angiographic factors. The only limitation was reduced
accuracy (77% [177 of 222 segments], p < 0.001) due to false positive
results (16%) in hypokinetic segments. Conclusions. No change and isc
hemic responses during DASE were specific for fixed dysfunction. Impro
ved wall thickening at the low dose, irrespective of changes at peak d
ose, was highly predictive of reversible dysfunction. Accuracy was onl
y limited by false positive results in hypokinetic segments and not by
the test interval or clinical or angiographic factors. (C) 1997 by th
e American College of Cardiology.